Pharming Group, a global biopharmaceutical company, has launched approximately €100m (US$107m) senior unsecured convertible bonds due 2029 and concurrently invited current holders of its outstanding €125m 3.00% convertible bonds due 2025…
The Netherlands: Pharming Group launches €100m convertible notes and buys back due 2025s
…
…






